Category: Finance
-
NIH Funding Single Home Test for Covid-19, Influenza, RSV
A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases.
-
Venture Fund to Back Life Science A.I. Start-Ups
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field.
-
Infographic – Venture Funds Continue Slide in Q2
Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year.
-
A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds
A company developing area sensors for smart homes that combine WiFi technology with machine learning algorithms is raising $10.5 million in venture funds.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Infographic – Biotech Index Shows Life, Ends Flat This Year
The Nasdaq Biotechnology Index, an indicator of investor sentiment in science-based businesses, bounced back from its 2023 low point, but still ended down slightly for the year on 30 June.
-
Weather Balloon Data Company Raises $6M in Seed Funds
A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds.
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.
-
Crop Health Device Company Raises $3.5M in Early Funds
A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round.
-
Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds.